The University of Pennsylvania Perelman School of Medicine (Penn) Gastroenterology (GI) Training Program has been instrumental in the development of academic research careers for gastroenterology trainees since 1963. During the last 15 years, there has been a tremendous expansion of biomedical research. The Penn GI Training Program has increased its base of basic science faculty coupled with impressive growth and maturation of the adult and pediatric GI divisions. Trainees have outstanding opportunities to pursue molecular and cellular biology in the field of gastroenterology, including hepatology and pancreatology. Direction: The Program Director (Dr. Anil Rustgi) and Associate Director (Dr. Gary Wu) have an administrative structure that oversees the needs of the Training Program, assisted by an Internal Advisory Board and an External Advisory Board. They are complemented by rigorous individual trainee research advisory committees. Faculty: Research faculty from the Adult and Pediatric GI divisions and basic science departments are selected based upon experience with trainees, independent and externally funded laboratories, and relevant projects in digestive, liver and pancreatic diseases. The faculty is grouped by research interests; we refer to them as affinity or thematic groups: 1) Developmental biology and genetics; 2) Immunobiology and host responses; and 3) Cell growth and differentiation. Proposed Training: The cornerstone of the Program is an intensive laboratory-based research experience (basic and translational), which entails close interaction with a training program faculty mentor and close oversight by a research advisory committee and the administrative structure. This laboratory work is supplemented by an educational curriculum that includes an introductory course in molecular and cellular biology, selected University courses, research seminars and lectures, journal clubs, written and oral research presentations, and seminars on extramural funding and the bioethics of scientific research. Candidates: Outstanding trainees with MD or MD-PhD degrees (postdoctoral fellows) or occasionally PhD degrees enter the Program from the Adult and Pediatric GI Fellowship Programs after being selected through a nationally competitive application process. Additionally, there has been growth in Penn's Physician-Scientist Residency Pathway (short-track internal medicine residents pursuing GI fellowship) and new avenues have emerged to identify future trainees in gastroenterology, including through our NIDDK R25 undergraduate training grant and our medical student T32 training grant supplements.

Public Health Relevance

Gastroenterology is a multidisciplinary field including approaches in basic science and translational medicine. It is vital to improve diagnosis and therapy of gastrointestinal diseases and disorders through research discoveries. The future of gastroenterology is predicated upon the development and growth of young physician-scientists and basic scientists. The University of Pennsylvania Perelman School of Medicine Gastroenterology Training Program has had historic success, and continues to be on the leading edge of nurturing young researchers and ensuring their maturation as leading investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007066-45
Application #
9748495
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Densmore, Christine L
Project Start
1975-07-01
Project End
2020-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
45
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Correnti, Jason M; Gottshall, Lauren; Lin, Annie et al. (2018) Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells. Sci Rep 8:12923
Vajravelu, Ravy K; Mamtani, Ronac; Scott, Frank I et al. (2018) Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study. Gastroenterology 155:1416-1427
Vajravelu, Ravy K; Scott, Frank I; Mamtani, Ronac et al. (2018) Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data. J Am Med Inform Assoc 25:780-789
Wangensteen, Kirk J; Wang, Yue J; Dou, Zhixun et al. (2018) Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology 68:663-676
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Maehara, Osamu; Suda, Goki; Natsuizaka, Mitsuteru et al. (2017) Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis 38:1073-1083
Whelan, Kelly A; Merves, Jamie F; Giroux, Veronique et al. (2017) Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis. Gut 66:1197-1207
Ni, Josephine; Wu, Gary D; Albenberg, Lindsey et al. (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14:573-584
Tomov, Vesselin T; Palko, Olesya; Lau, Chi Wai et al. (2017) Differentiation and Protective Capacity of Virus-Specific CD8+ T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche. Immunity 47:723-738.e5
Papamichael, Konstantinos; Chachu, Karen A; Vajravelu, Ravy K et al. (2017) Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab. Clin Gastroenterol Hepatol 15:1580-1588.e3

Showing the most recent 10 out of 100 publications